Page last updated: 2024-09-02

3,5-dihydroxyphenylglycine and raclopride

3,5-dihydroxyphenylglycine has been researched along with raclopride in 1 studies

Compound Research Comparison

Studies
(3,5-dihydroxyphenylglycine)
Trials
(3,5-dihydroxyphenylglycine)
Recent Studies (post-2010)
(3,5-dihydroxyphenylglycine)
Studies
(raclopride)
Trials
(raclopride)
Recent Studies (post-2010) (raclopride)
3011611,802132419

Protein Interaction Comparison

ProteinTaxonomy3,5-dihydroxyphenylglycine (IC50)raclopride (IC50)
D(2) dopamine receptorHomo sapiens (human)0.052
D(2) dopamine receptorMus musculus (house mouse)0.032
D(2) dopamine receptorRattus norvegicus (Norway rat)0.0279

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amalric, M; Breysse, N; Risterucci, C1

Other Studies

1 other study(ies) available for 3,5-dihydroxyphenylglycine and raclopride

ArticleYear
D1 and D2 dopamine receptors contribute to the locomotor response induced by Group II mGluRs activation in the rat nucleus accumbens.
    Pharmacology, biochemistry, and behavior, 2002, Volume: 73, Issue:2

    Topics: Amino Acids, Dicarboxylic; Animals; Benzazepines; Dopamine Antagonists; Drug Interactions; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Glycine; Male; Microinjections; Motor Activity; Nucleus Accumbens; Raclopride; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Metabotropic Glutamate; Resorcinols; Stimulation, Chemical

2002